Cite
Compte M, Harwood SL, Erce-Llamazares A, et al. An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity. Clin Cancer Res. 2021;27(11):3167-3177doi: 10.1158/1078-0432.CCR-20-4625.
Compte, M., Harwood, S. L., Erce-Llamazares, A., Tapia-Galisteo, A., Romero, E., Ferrer, I., Garrido-Martin, E. M., Enguita, A. B., Ochoa, M. C., Blanco, B., Oteo, M., Merino, N., Nehme-Álvarez, D., Hangiu, O., Domínguez-Alonso, C., Zonca, M., Ramírez-Fernández, A., Blanco, F. J., Morcillo, M. A., Muñoz, I. G., Melero, I., Rodriguez-Peralto, J. L., Paz-Ares, L., Sanz, L., & Alvarez-Vallina, L. (2021). An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(11), 3167-3177. https://doi.org/10.1158/1078-0432.CCR-20-4625
Compte, Marta, et al. "An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,11 (2021): 3167-3177. doi: https://doi.org/10.1158/1078-0432.CCR-20-4625
Compte M, Harwood SL, Erce-Llamazares A, Tapia-Galisteo A, Romero E, Ferrer I, Garrido-Martin EM, Enguita AB, Ochoa MC, Blanco B, Oteo M, Merino N, Nehme-Álvarez D, Hangiu O, Domínguez-Alonso C, Zonca M, Ramírez-Fernández A, Blanco FJ, Morcillo MA, Muñoz IG, Melero I, Rodriguez-Peralto JL, Paz-Ares L, Sanz L, Alvarez-Vallina L. An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity. Clin Cancer Res. 2021 Jun 01;27(11):3167-3177. doi: 10.1158/1078-0432.CCR-20-4625. Epub 2021 Mar 30. PMID: 33785484.
Copy
Download .nbib